PrEP Effective for Preventing HIV
Pre-exposure prophylaxis (PrEP) is highly effective for preventing HIV. PrEP reduces the risk of getting HIV from sex by about 99% and from injecting drugs by at least 74% when taken as prescribed. The two pills approved for use as PrEP are Truvada and Descovy. Apretude is the only shot approved for use as PrEP. Apretude is the first and only long-acting, injectable PrEP for reducing the risk of getting HIV. See the Figure below. Apretude is designed to continuously help prevent the risk of getting HIV when taken every other month. Apretude is for people at risk through sex who weigh at least 77 pounds (35 kg). You must get tested to make sure that you do not already have HIV-1 infection. You must be HIV-1 negative to start Apretude. Protect yourself from HIV. IPH is located at 9053 Woodward Ave, Detroit, Monday to Friday, 8:30 AM to 4:00 PM. Call 313-309-9350 ext. 2 for more information on HIV testing, PrEP, and PEP.

https://apretude.com/about-prep/what-is-prep/
https://www.cdc.gov/stophivtogether/hiv-prevention/prep.html
https://www.cdc.gov/hiv/prevention/prep.html
https://www.cdc.gov/hiv/risk/estimates/preventionstrategies.html#anchor_1562942347
https://apretude.com/
https://apretude.com/risks-and-side-effects/
https://www.cdc.gov/stophivtogether/library/topics/prevention/brochures/cdc-lsht-prevention-brochure-clinicians-quick-guide-what-is-hiv-prep.pdf
https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf